Alnylam Pharmaceuticals Stock News

White House health advisor Dr. Anthony Fauci made his comments Friday on CNBC.

Alnylam (ALNY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

WASHINGTON - Former defense secretary Jim Mattis' strong rebuke of President Donald Trump forced Republicans to choose sides between a revered retired Marine Corps general and a leader with a near-str

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen

The United Nations is among organizations urging those companies developing coronavirus vaccines to create one that would be free to everyone once it's developed

Regeneron has both added to its current growth drivers and developed an impressive pipeline that should fuel performance throughout the decade. Eylea will benef

In study results published last week, the Gilead drug seemed to get patients off a ventilator sooner than existing treatments. But an analyst notes the anomaly that patients on the drug for 5 days did

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that seven patient advocacy groups will receive supportive funding as part of the company’s secon

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Regeneron Oncology Investor Event, ASCO 2020 Conference Call June 01, 2020 04:30 PM ET Company Participants Justin

Comments likely to raise fears he is being squeezed out of White House as coronavirus continues to ravage US

UK’s 14-day quarantine rules criticised as ‘ridiculous’; Global deaths near 375,000; Spain reports no new deaths for the first time since March. Follow the latest updates

Four years after Regeneron Pharmaceuticals and Intellia Therapeutics began working together to research the use of CRISPR/Cas9 to treat liver diseases,